Mechanism of Wulan Shisanwei Tangsan in Protecting Against Cerebral Ischemia-reperfusion Injury by Regulating the cGAS-STING Pathway
刊名 Medicinal Plant
作者 Yanbin LI, Chunhui LIU*, Hanrui BAI, Wenling CONG, Lifen WANG, Zeyu WU, Qin WANG, Jiawei LIU
作者单位 College of Traditional Chinese Medicine, Inner Mongolia Medical University
DOI DOI:10.19600/j.cnki.issn2152-3924.2026.05.015
年份 2026
刊期 5
页码 81-85
关键词 Cerebral ischemia-reperfusion, cGAS-STING, Neuroinflammation, Wulan Shisanwei Tangsan, Mongolian medicine
摘要 [Objectives] This study was conducted to investigate the protective effect of the Mongolian medicine Wulan Shisanwei Tangsan (WL-13) against cerebral ischemia-reperfusion injury (CIRI) and its regulatory mechanism on the cGAS-STING pathway. [Methods] An SD rat MCAO/R model and OGD/R-injured astrocytes were adopted, and different doses of WL-13 (0.22, 0.44, 0.88 g/kg/d) were administered for intervention. Cerebral infarct area was assessed by TTC staining. The levels of inflammatory cytokines (TNF-α, IL-6, IL-1β) and cyclic nucleotides (cAMP, cGMP, cGAMP) were measured by ELISA to evaluate the regulatory effects of WL-13 on the cGAS-STING-NF-κB pathway and neuroinflammation. [Results] WL-13 reduced cerebral infarct size in MCAO/R rats in a dose-dependent manner and improved neurological deficits. It decreased the levels of TNF-α, IL-6, IL-1β, cGMP, and cGAMP, and increased cAMP levels in hippocampal tissue and astrocyte supernatants. The high-dose group (0.88 g/kg/d) exhibited the most pronounced effects. [Conclusions] WL-13 attenuated CIRI by inhibiting the cGAS-STING-NF-κB-mediated neuroinflammatory cascade. This study provides an experimental pharmacological basis for the clinical application of WL-13 and the modern development of Mongolian medicine.